Sign In
Buy PFE
$26.04
+0.345 (+1.34%)
At Close: Jun 05, 2026
Haleon's buy rating restated after Pfizer cuts down stake
07:35am, Tuesday, 01'st Oct 2024
UBS has reiterated its buy rating on Haleon PLC (LSE:HLN, NYSE:HLN) shares after news that former parent company Pfizer Inc (NYSE:PFE, ETR:PFE) further pared down its stake in the FTSE 100-listed Sens
Haleon buys back some shares as Pfizer sells down stake
02:32am, Tuesday, 01'st Oct 2024
Haleon PLC (LSE:HLN, NYSE:HLN) said it has agreed to buy £230 million of its own shares from former co-parent Pfizer Inc (NYSE:PFE, ETR:PFE), which offloaded almost a $3.3 billion stake in the Sensod
Pfizer offloads $3.3 bln stake in Sensodyne-maker Haleon
02:13am, Tuesday, 01'st Oct 2024
Pfizer offloaded shares worth roughly $3.26 billion in Haleon at 380 pence apiece, cutting its stake to 15% in the world's largest standalone consumer healthcare firm, a bookrunner said on Tuesday.
Pfizer: Growth From Oncology Franchise; Initiate With 'Buy'
12:53am, Tuesday, 01'st Oct 2024
Pfizer's acquisition of Seagen for $43 billion enhances its ADC technology, potentially expanding its oncology franchise and driving future growth. PFE's development of the oral GLP-1 receptor agonist
Pfizer to offload about 5.9% stake in UK's Haleon, says bookrunner
12:14pm, Monday, 30'th Sep 2024
Pfizer intends to offload about 540 million shares in the British consumer healthcare company Haleon , a bookrunner said on Monday.
Buy These Top 5 Price-to-Sales Stocks for Better Investment Returns
10:25am, Monday, 30'th Sep 2024
The price-to-sales ratio is a convenient tool to gauge the value of stocks incurring losses or in an early development cycle. Stocks like GIII, SON, HG, PAM and PFE hold promise.
15 Best Dividend Stocks for Lifelong Passive Income
06:15am, Monday, 30'th Sep 2024
Dividend sustainability trumps high yields when selecting stocks for passive income. The featured companies span diverse sectors including healthcare, consumer goods, retail, finance, and real estate.
3 Surprisingly Underrated Stocks to Buy Right Now
07:30am, Saturday, 28'th Sep 2024
Bristol Myers Squibb is trading at a significant discount. Moderna has a lot of irons in the fire.
PFE vs. NVO: Which Stock Is the Better Value Option?
12:46pm, Friday, 27'th Sep 2024
Investors interested in stocks from the Large Cap Pharmaceuticals sector have probably already heard of Pfizer (PFE) and Novo Nordisk (NVO). But which of these two stocks presents investors with the b
4 High Earnings Yield Stocks That Value Investors Should Buy Now
10:26am, Friday, 27'th Sep 2024
Unlock your portfolio value by investing in these high-earnings stocks like PPC, PFE, IAG and ASIX.
Pfizer: A 6% Yielding Value Deal
09:31am, Friday, 27'th Sep 2024
Pfizer remains an attractive capital return play with a 10X P/E ratio, despite concerns about post-COVID revenue declines. The oncology business shows promising growth, particularly with products like
Buy These 4 S&P 500 Year-to-Date Laggards With Solid Near-Term Upside
09:11am, Friday, 27'th Sep 2024
Four S&P 500 laggards of this year have double-digit upside left for the rest of 2024. These are: CCL, PFE, ZTS, TDY.
Pfizer (PFE) Rises But Trails Market: What Investors Should Know
06:50pm, Thursday, 26'th Sep 2024
Pfizer (PFE) closed the most recent trading day at $28.97, moving +0.14% from the previous trading session.
FDA alerts patients about Pfizer's Oxbryta withdrawal
03:41pm, Thursday, 26'th Sep 2024
The U.S. Food and Drug Administration on Thursday alerted patients and healthcare professionals about the withdrawal of Pfizer's sickle cell disease treatment Oxbryta.
Pfizer Withdraws Sickle Cell Disease Therapy Oxbryta From Market
12:41pm, Thursday, 26'th Sep 2024
PFE's decision is based on clinical data, which suggests that the overall benefit of the drug no longer outweighs the risk in the approved patient population.
